Kiri

Dokumendiregister Terviseamet
Viit 11.1-2/24/3146-2
Registreeritud 25.03.2024
Sünkroonitud 26.03.2024
Liik Väljaminev dokument
Funktsioon 11.1 Turustamise järgne järelevalve (post-marketing surveillance)
Sari 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
Toimik 11.1-2/2024
Juurdepääsupiirang Avalik
Juurdepääsupiirang
Adressaat Mediprime Ventures
Saabumis/saatmisviis Mediprime Ventures
Vastutaja Jaak Raud (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)
Originaal Ava uues aknas

Failid

Vs_ Medical device implementation on market .msg
image001.png

From: "Meditsiiniseadmed (Medical Devices)" <mso@terviseamet.ee>
Sent: Fri, 22 Mar 2024 05:48:46 +0000
To: "mediprime.ventures@gmail.com" <mediprime.ventures@gmail.com>
Subject: Vs: Medical device implementation on market

Dear Miks,

 

Thank you for your inquiry.

 

The distribution notification can be done through Estonian Medical Device Database (EMDDB, https://msa.sm.ee/).

 

For actors outside of Estonia we can make an account manually, so it is possible to log into the database with username and password. For creating an account we need a contact person’s full name, e-mail and the position in the company. 

Therefore, does the account go to your name?

 

Documents with the notifications of medical devices are following: Declaration of conformity, EC certificate, instruction for use in English, instruction for use in Estonian and copy of the labelling or packaging.

 

Also, please use a short guide for using the Estonian Medical Device Database that can be found on database homepage under „Forms“.

 

NB! Please note that the access to the database is limited to users outside of Estonia.

In case of this, please contact with abi@tehik.ee with an request to access to the database and your IP address. They will white-list your IP and you should have an access to the database.

 

This is a temporary restriction for security reasons which hopefully will be removed in near future.

 

Please do not hesitate to contact me for further information or any questions.

 

Kind regards

 

 

Jaak Raud

Chief Specialist

Department of Medical Devices

+372 5561 0969

jaak.raud@terviseamet.ee

 

Republic of Estonia

Health Board

+372 794 3500

info@terviseamet.ee

www.terviseamet.ee

Paldiski mnt 81, 10614 Tallinn

Estonia

 

This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments.

 

 

 

 

Saatja: mediprime.ventures@gmail.com <mediprime.ventures@gmail.com>
Saatmisaeg: neljapäev, 21. märts 2024 12:37
Adressaat: Meditsiiniseadmed (Medical Devices) <mso@terviseamet.ee>
Teema: Medical device implementation on market

 

Tere,

 

Hope you have good day!

 

We are Medical Device distributors.

We just did the same procedure in Latvia, but we will work with Estonia as well.

 

1) We need to an application about take our company in Estonian state Databaseu. 

2) We must submit application for taking Medical device in to market. 

 

To Zylox and Tonbridge documents I will add CE certificates and declarations of conformity and all submissions signed by electronic signatures and send to Health Board email. Would you please be so kind and advise me on this? 

 

 

Kind regards

 

Miks Lormanis
Sales managing director
+371 20022753 (what’s up)
+380 68 965 4833
MediPrime.ventures@gmail.com


 

 

 

Seosed

Nimi K.p. Δ Viit Tüüp Org Osapooled
Kiri 25.03.2024 1 11.1-2/24/3146-3 🔒 Sissetulev dokument ta SIA Mediprime Ventures
Kiri 25.03.2024 1 11.1-2/24/3146-4 🔒 Väljaminev dokument ta SIA Mediprime Ventures